Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients
NCT01291459
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir
Sponsor
Association Pour la Recherche en Infectiologie